Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2024 Earnings Call Transcript March 4, 2025
Y-mAbs Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.13.
Operator: Good morning, and welcome to Y-mAbs Therapeutics, Inc.’s Earnings Conference Call for the Fourth Quarter and Full Year 2024. [Operator Instructions] As a reminder, today’s conference will be recorded. I would now like to hand the call over to Y-mAbs’ Head of IR, Courtney...
